| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,188,023 | 1,111,826 | 1,081,914 | 1,105,299 | | Cost of Revenue | 464,213 | 612,984 | 903,523 | 448,617 | | | Gross Profit | 723,810 | 498,842 | 178,391 | 656,682 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 396,434 | 221,868 | (87,731) | 368,566 | | Non Recurring |
-
| 130,229 | 378,001 |
-
| | Others | 204,899 | 60,455 | (193,976) | 184,463 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 122,477 | 86,290 | 82,097 | 103,653 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,677 | 27,168 | (7,845) | (4,650) | | Earnings Before Interest And Taxes | 139,154 | 108,204 | 69,683 | 93,618 | | Interest Expense | 55,011 | 61,663 | 56,226 | 58,656 | | Income Before Tax | 84,143 | 46,541 | 13,457 | 34,962 | | Income Tax Expense | 30,066 | 17,498 | 2,729 | 13,039 | | Minority Interest |
-
| (5,254) | (4,569) | (5,385) | | | | Net Income From Continuing Ops | 54,077 | 29,043 | 10,728 | 21,923 | | | Non-recurring Events | | Discontinued Operations | (1,508) | (14,494) | (4,325) | (9,526) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 52,569 | 14,549 | 6,403 | 12,397 | | Preferred Stock And Other Adjustments | (6,553) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $46,016 | $14,549 | $6,403 | $12,397 |
|
0.45% Nasdaq 
0.20%
Income Statement
